""Thank you for your interest in Vida Clinical Research Studies. We are trusted by leading pharmaceutical companies to recruit the right patients to test cutting-edge medicine for tomorrow's treatments. Our expert staff takes great care to ensure patient safety"."

During the past decade, Vida Clinical Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Vida Clinical Research" are "Rheumatoid Arthritis" (1 trials) and "Systemic Lupus Erythematosus" (1 trials). Many other conditions were trialed in "Vida Clinical Research" in a lesser frequency.

Most popular intervention types in "Vida Clinical Research" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Afimetoran" (1 trials), "Placebo" (1 trials) and "TC99m-tilmanocept" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vida Clinical Research" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Vida Clinical Research". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Vida Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Vida Clinical Research, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".